Patents by Inventor Vincent Brett Cooper

Vincent Brett Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral pharmaceutical formulation of omarigliptin
    Patent number: 9937153
    Abstract: The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight of the pharmaceutical formulation and comprises at least one non-reducible sugar diluent or a mixture of non-reducible sugar diluents.
    Type: Grant
    Filed: August 25, 2014
    Date of Patent: April 10, 2018
    Assignees: Merck Sharp & Dohme LTD., Merck Sharp & Dohme Corp.
    Inventors: Vincent Brett Cooper, Kathryn Alanna Bradley, Samuel Robert Pygall, Rajan Gupta, Madison Paige Stanford, Lin Xie
  • ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN
    Publication number: 20160166544
    Abstract: The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight of the pharmaceutical formulation and comprises at least one non-reducible sugar diluent or a mixture of non-reducible sugar diluents.
    Type: Application
    Filed: August 25, 2014
    Publication date: June 16, 2016
    Inventors: Vincent Brett Cooper, Kathryn Alanna Bradley, Samuel Robert Pygall, Rajan Gupta, Madison Paige Stanford, Lin Xie
  • Polymorphic forms of a GABA agonist
    Patent number: 8236958
    Abstract: Two new crystalline monohydrates and two new crystalline anhydrates of gaboxadol are disclosed together with methods for preparing them.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: August 7, 2012
    Assignee: H. Lundbeck A/S
    Inventor: Vincent Brett Cooper
  • Polymorphic forms of a GABAagonist
    Patent number: 7262300
    Abstract: Two new crystalline monhydrates and two new crystalline anhydrates of gaboxadol are disclosed together with methods for preparing them.
    Type: Grant
    Filed: January 28, 2005
    Date of Patent: August 28, 2007
    Assignee: Merck Sharp & Dohme Ltd.
    Inventor: Vincent Brett Cooper